Suppr超能文献

相似文献

1
3'-functionalized adamantyl cannabinoid receptor probes.
J Med Chem. 2015 Apr 9;58(7):3104-16. doi: 10.1021/jm501960u. Epub 2015 Mar 20.
2
Adamantyl cannabinoids: a novel class of cannabinergic ligands.
J Med Chem. 2005 Jul 14;48(14):4576-85. doi: 10.1021/jm058175c.
3
Heteroadamantyl cannabinoids.
J Med Chem. 2010 Aug 12;53(15):5656-66. doi: 10.1021/jm100390h.
4
Oxaza adamantyl cannabinoids. A new class of cannabinoid receptor probes.
J Org Chem. 2006 Sep 29;71(20):7800-4. doi: 10.1021/jo061352c.
5
Oxa-adamantyl cannabinoids.
Bioorg Med Chem Lett. 2021 Apr 15;38:127882. doi: 10.1016/j.bmcl.2021.127882. Epub 2021 Feb 24.
6
Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.
J Med Chem. 2008 Oct 23;51(20):6393-9. doi: 10.1021/jm8005299. Epub 2008 Oct 1.
8
C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.
Bioorg Med Chem Lett. 2012 Aug 15;22(16):5322-5. doi: 10.1016/j.bmcl.2012.06.013. Epub 2012 Jun 15.
9
Novel adamantyl cannabinoids as CB1 receptor probes.
J Med Chem. 2013 May 23;56(10):3904-21. doi: 10.1021/jm4000775. Epub 2013 May 14.

引用本文的文献

1
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders.
Front Psychiatry. 2022 Jun 14;13:828895. doi: 10.3389/fpsyt.2022.828895. eCollection 2022.
2
Covalent cannabinoid receptor ligands - structural insight and selectivity challenges.
RSC Med Chem. 2022 Apr 4;13(5):497-510. doi: 10.1039/d2md00006g. eCollection 2022 May 25.
3
Cannabinoids and Cannabinoid Receptors: The Story so Far.
iScience. 2020 Jul 24;23(7):101301. doi: 10.1016/j.isci.2020.101301. Epub 2020 Jun 20.
4
Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes.
ChemMedChem. 2020 Aug 5;15(15):1374-1389. doi: 10.1002/cmdc.202000298. Epub 2020 Jun 24.
5
Synthesis of Functionalized Cannabilactones.
Molecules. 2020 Feb 6;25(3):684. doi: 10.3390/molecules25030684.
6
Allosteric Modulation of Cannabinoid Receptor 1-Current Challenges and Future Opportunities.
Int J Mol Sci. 2019 Nov 22;20(23):5874. doi: 10.3390/ijms20235874.
7
Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor.
Molecules. 2019 Oct 1;24(19):3559. doi: 10.3390/molecules24193559.
8
Crystal Structure of the Human Cannabinoid Receptor CB2.
Cell. 2019 Jan 24;176(3):459-467.e13. doi: 10.1016/j.cell.2018.12.011. Epub 2019 Jan 10.
9
Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB Receptor Expression and Ligand Engagement in Human Cells.
J Am Chem Soc. 2018 May 16;140(19):6067-6075. doi: 10.1021/jacs.7b11281. Epub 2018 Feb 16.
10
A covalent antagonist for the human adenosine A receptor.
Purinergic Signal. 2017 Jun;13(2):191-201. doi: 10.1007/s11302-016-9549-9. Epub 2016 Dec 3.

本文引用的文献

1
Synthesis and Biological Evaluation of a Cyclo-β-tetrapeptide as a Somatostatin Analogue.
Angew Chem Int Ed Engl. 1999 May 3;38(9):1223-1226. doi: 10.1002/(SICI)1521-3773(19990503)38:9<1223::AID-ANIE1223>3.0.CO;2-A.
2
2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.
J Med Chem. 2014 May 22;57(10):3891-911. doi: 10.1021/jm500220s. Epub 2014 May 1.
3
Controlled-deactivation cannabinergic ligands.
J Med Chem. 2013 Dec 27;56(24):10142-57. doi: 10.1021/jm4016075. Epub 2013 Dec 10.
4
Novel adamantyl cannabinoids as CB1 receptor probes.
J Med Chem. 2013 May 23;56(10):3904-21. doi: 10.1021/jm4000775. Epub 2013 May 14.
8
Heteroadamantyl cannabinoids.
J Med Chem. 2010 Aug 12;53(15):5656-66. doi: 10.1021/jm100390h.
10
Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.
J Med Chem. 2008 Oct 23;51(20):6393-9. doi: 10.1021/jm8005299. Epub 2008 Oct 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验